Piramal Pharma Ltd Quarterly Results

Gross Sales

2,754.07

2,204.22

2,241.75

1,951.14

2,552.36

Excise Duty

0

0

0

0

0

Net Sales

2,754.07

2,204.22

2,241.75

1,951.14

2,552.36

Other Operating Income

0

0

0

0

0

Other Income

58.25

29.18

78.37

41.94

38.42

Total Income

2,812.32

2,233.4

2,320.12

1,993.08

2,590.78

Total Expenditure

2,193.08

1,866.48

1,900.14

1,746.65

2,052.95

PBIDT

619.24

366.92

419.98

246.43

537.83

Interest

103.68

103.31

107.64

106.96

114.22

PBDT

515.56

263.61

312.34

139.47

423.61

Depreciation

242.76

196.81

192.22

184.55

196.13

Minority Interest Before NP

0

0

0

0

0

Tax

93.81

71.98

94.27

50.06

100.93

Deferred Tax

25.49

-8.86

3.26

-6.5

25.28

Reported Profit After Tax

153.5

3.68

22.59

-88.64

101.27

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

153.5

3.68

22.59

-88.64

101.27

Extra-ordinary Items

0

0

0

0

-13.59

Adjusted Profit After Extra-ordinary item

153.5

3.68

22.59

-88.64

114.86

EPS (Unit Curr.)

1.16

0.03

0.17

-0.67

0.77

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

1,324.35

1,323.58

1,323.14

1,322.95

1,322.95

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.48

16.64

18.73

12.63

21.07

PBDTM(%)

18.71

11.95

13.93

7.14

16.59

PATM(%)

5.57

0.16

1

-4.54

3.96